Rocatinlimab Biosimilar - Research Grade

Human

TNFRSF4ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P43489

Blue ice

TNFRSF4 (OX40) is a co-stimulatory receptor on activated T cells that amplifies effector responses and sustains immune memory, making it a focal point of immuno-oncology and autoimmunity research. Our anti-OX40 recombinant antibody is a non-therapeutic, unconjugated analog of rocatinlimab developed for research use only. Manufactured to rigorous in vivo standards, this ultra-pure, low-endotoxin preparation is available in scalable milligram to gram quantities to meet the demands of high-throughput laboratories. Researchers can apply it as a control and active reagent across in vitro screening, T-cell signaling studies, and in vivo immune-modulation models. Consistent lot-to-lot performance makes it a dependable reagent for laboratories that consume reagents in bulk.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.